MGMT and central nervous system cancer: Further extending the application of IVIM, Lu et al. [50] demonstrated its potential in predicting the methylation status of O6-methylguanine-DNA-methyltransferase (MGMT) in gliomas, with IVIM parameters showing sensitivity and specificity comparable to or exceeding those of DSC imaging.